Ischaemic stroke and essential thrombocythemia: a series of 14 cases

The contribution of cyclooxygenase-1 and -2 to persistent thromboxane biosynthesis in aspirin-treated essential thrombocythemia: implications for antiplatelet therapy

(2009) A. Dragani et al.   BLOOD

Lacunar stroke

(2009) Adrià Arboix et al.   Expert Review of Neurotherapeutics

Increase in leukocyte count over time predicts thrombosis in patients with low-risk essential thrombocythemia

(2009) F. PASSAMONTI et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Platelet turnover, coagulation factors, and soluble markers of platelet and endothelial activation in essential thrombocythemia: Relationship with thrombosis occurrence andJAK2 V617F allele burden

(2008) Eduardo Arellano-Rodrigo et al.   AMERICAN JOURNAL OF HEMATOLOGY

TheJAK2V617Fmutation and thrombosis

(2008) S. K. Austin et al.   BRITISH JOURNAL OF HAEMATOLOGY

Recurrent thrombosis in patients with polycythemia vera and essential thrombocythemia: incidence, risk factors, and effect of treatments

(2008) V. De Stefano et al.   HAEMATOLOGICA